Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjogren's syndrome

被引：24
|
作者：
Nordal, H. H. [1 ,2 ]
Brun, J. G. [1 ,2 ]
Halse, A-K [1 ,2 ]
Madland, T. M. [2 ]
Fagerhol, M. K. [3 ]
Jonsson, R. [1 ,2 ]
机构：
[1] Univ Bergen, Dept Clin Sci, N-5020 Bergen, Norway
[2] Haukeland Hosp, Dept Rheumatol, N-5021 Bergen, Norway
[3] Prof Fagerhols Res Lab, Oslo, Norway
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2014年 / 43卷 / 01期
关键词：
EXPRESSION; ARTHRITIS; PROTEINS; DISEASES; RECEPTOR; CALCIUM; CELLS; RAGE;
D O I：
10.3109/03009742.2013.848930
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 78
页数：4
相关论文
共 50 条
  • [1] Prospective evaluation of S100A12 and S100A8/A9 (calprotectin) in dogs with sepsis or the systemic inflammatory response syndrome
    Thames, Brittany E.
    Barr, James W.
    Suchodolski, Jan S.
    Steiner, Joerg M.
    Heilmann, Romy M.
    JOURNAL OF VETERINARY DIAGNOSTIC INVESTIGATION, 2019, 31 (04) : 645 - 651
  • [2] S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis
    Baillet, A.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 458 - 461
  • [3] Large molecular size EDTA-resistant complexes containing S100A12, ERAC, in serum during inflammatory conditions
    Fagerhol, Magne K.
    Larsen, Annette
    Brun, Johan G.
    Hammer, Hilde B.
    Angel, Kristin
    Kvien, Tore K.
    Kinne, Ingebjorg
    Madland, Tor M.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (02): : 129 - 136
  • [4] Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunity
    Xia, Pengpeng
    Ji, Xingduo
    Yan, Li
    Lian, Siqi
    Chen, Ziyue
    Luo, Yi
    IMMUNOLOGY, 2024, 171 (03) : 365 - 376
  • [5] Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases
    Lorenz, Eva
    Muhlebach, Marianne S.
    Tessier, Philippe A.
    Alexis, Neil E.
    Hite, R. Duncan
    Seeds, Michael C.
    Peden, David B.
    Meredith, Wayne
    RESPIRATORY MEDICINE, 2008, 102 (04) : 567 - 573
  • [6] S100A12 and S100A8/9 proteins are biomarkers of articular disease activity in Blau syndrome
    Wang, Lin
    Rose, Carlos D.
    Foley, Kevin P.
    Anton, Jordi
    Bader-Meunier, Brigitte
    Brissaud, Philippe
    Chedeville, Gaelle
    Cimaz, Rolando
    Fernandez-Martin, Jorge
    Guly, Catherine
    Hachulla, Eric
    Harjacek, Miroslav
    Mackensen, Friederike
    Merino, Rosa
    Modesto, Consuelo
    Naranjo Hernandez, Antonio
    Pajot, Christine
    Ramanan, Athimalaipet V.
    Thatayatikom, Akaluck
    Thomee, Caroline
    Vastert, Sebastiaan
    Votta, Bart J.
    Bertin, John
    Wouters, Carine H.
    RHEUMATOLOGY, 2018, 57 (07) : 1299 - 1304
  • [7] S100A8/A9 and S100A12 may be biomarkers for juvenile-onset systemic lupus erythematosus
    Donohue, Sean Joseph
    Midgley, Angela
    Bruce, Ian
    Beresford, Michael W.
    Hedrich, Christian M.
    RHEUMATOLOGY, 2019, 58
  • [8] A pilot study of S100A4, S100A8/A9, and S100A12 in dilated cardiomyopathy: novel biomarkers for diagnosis or prognosis?
    Yu, Ying
    Shi, Hui
    Wang, Yucheng
    Yu, Yong
    Chen, Ruizhen
    ESC HEART FAILURE, 2024, 11 (01): : 503 - 512
  • [9] Increased plasma levels of S100A8, S100A9, and S100A12 in chronic spontaneous urticaria
    Zhou, Qjong-Yan
    Lin, Wei
    Zhu, Xiao-Xia
    Xu, Su-Ling
    Ying, Meng-Xia
    Shi, Lei
    Lin, Bing-Jiang
    INDIAN JOURNAL OF DERMATOLOGY, 2019, 64 (06) : 441 - 446
  • [10] Calprotectin (S100A8/A9) and S100A12 are associated with measures of disease activity in a longitudinal study of patients with rheumatoid arthritis treated with infliximab
    Nordal, H. H.
    Brun, J. G.
    Hordvik, M.
    Eidsheim, M.
    Jonsson, R.
    Halse, A-K
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 (04) : 274 - 281
12345